肝胆相照论坛

标题: Genotype impact on long-term virological outcome of chronic hepatitis B virus in [打印本页]

作者: StephenW    时间: 2012-5-31 23:23     标题: Genotype impact on long-term virological outcome of chronic hepatitis B virus in

本帖最后由 StephenW 于 2012-5-31 23:23 编辑

J Clin Virol. 2012 May 17. [Epub ahead of print]
Genotype impact on long-term virological outcome of chronic hepatitis B virus infection.Malmström S, Eilard A, Larsson SB, Hannoun C, Norkrans G, Lindh M.
Source
Department of Infectious Diseases, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Abstract
BACKGROUND: The importance of hepatitis B virus (HBV) genotype on the clinical course of chronic HBV infection is not yet clarified.
OBJECTIVES: To investigate genotype impact on long-term virological outcome of chronic HBV infection.
STUDY DESIGN: HBsAg, HBeAg, ALT and HBV DNA levels were determined after a median of 9.2years of follow-up of 124 adults with chronic HBV infection, of whom 33 were HBeAg-positive at inclusion.
RESULTS: HBV DNA levels decreased significantly in patients carrying genotype A (n=28), B (n=21) or D (n=63), but not in those with genotype C infection (n=12). Loss of HBeAg was seen in 44% (4/9) of patients with genotype C, as compared with 92% (22/24) with non-C genotypes. Loss of HBsAg was seen in 36% (10/28) patients with genotype A, 5% (1/21) with B, 0% (0/12) with C, and 11% (7/63) with genotype D.
CONCLUSIONS: HBV DNA levels decreased over time in patients infected with genotypes A, B or D. However, highly active genotype C or D infection often remained highly active, implying a risk for progressive liver damage.

作者: StephenW    时间: 2012-5-31 23:27

本帖最后由 StephenW 于 2012-5-31 23:28 编辑

参考临床病毒学杂志: 2012五月17日。 [出处提前打印]
长期慢性乙型肝炎病毒感染的病毒学结果的基因型影响。
马尔姆斯特伦小号,一个Eilard,拉尔森SB,Hannoun C,NorkransĞ,林德M.



部传染病Sahlgrenska学院,哥德堡,瑞典哥德堡大学。

摘要

背景:

B型肝炎病毒(HBV)基因型对慢性乙肝病毒感染的临床过程中的重要性尚未澄清。
目的:

调查基因型的影响,长期的慢性乙肝病毒感染的病毒学结果。
研究设计:

测定乙肝表面抗原,e抗原,ALT和HBV DNA水平中位数的124例慢性乙肝病毒感染的成人后续9.2年后,其中33例HBeAg阳性在列入。
结果:

携带基因型的患者HBV DNA水平显着下降,A组(n= 28),乙(N= 21)或D(N= 63),而不是在C基因型感染者(N =12)。 HBeAg的清除在44%(4/9)与C基因型患者,与92%(22/24)与非C基因型相比。 HBsAg的清除在36%(10/28)A基因型病人,与B的5%(1/21),0%(0/12)与C基因型, 11%(7/63)D基因型.
结论:

HBV DNA水平降低患者感染基因型,B或D。然而,高度活跃的基因型C或D感染的时间,经常保持高度活跃,这意味着一个渐进的肝功能损害的风险。
作者: 咬牙硬挺    时间: 2012-6-1 12:02

感谢分享




欢迎光临 肝胆相照论坛 (http://hbvhbv.info/forum/) Powered by Discuz! X1.5